Four major hospitals recently filed an emergency appeal to block Johnson & Johnson (J&J) from auditing their 340B programs—three months [...] …
Category: Regulatory
The Health Resources and Services Administration (HRSA) has now published 1,116 of the 1,243 comments it received on its controversial [...] …
A federal appeals court recently heard arguments in a case, which a group of Texas hospitals filed challenging a Department [...] …
Four major drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024, following recalculations [...] …
The Health Resources and Services Administration (HRSA) received more than 1,200 comments on its controversial 340B rebate pilot program ahead [...] …
A bipartisan group of 163 U.S. House members yesterday sent Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. [...] …
A national hospital trade group urged federal officials Monday to investigate whether five major drugmakers engaged in anticompetitive practices while [...] …
The American Hospital Association (AHA) is pushing back forcefully against the Health Resources and Services Administration’s (HRSA) new 340B rebate [...] …
A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...] …
Rural health advocates are sounding alarms over the surge in large urban hospitals reclassifying as rural under Medicare, warning this [...] …